Page last updated: 2024-10-23

aspirin and Soft Tissue Neoplasms

aspirin has been researched along with Soft Tissue Neoplasms in 1 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Soft Tissue Neoplasms: Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mendez, GM1
Patel, YM1
Ricketti, DA1
Gaughan, JP1
Lackman, RD1
Kim, TWB1

Other Studies

1 other study available for aspirin and Soft Tissue Neoplasms

ArticleYear
Aspirin for Prophylaxis Against Venous Thromboembolism After Orthopaedic Oncologic Surgery.
    The Journal of bone and joint surgery. American volume, 2017, Dec-06, Volume: 99, Issue:23

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Bone Neoplasms; Female; Humans;

2017